It suggested that the inhibition of GLS1 (Wu et al. 2021) or CCNE1 (Kawahara et al. 2021) could significantly suppress the proliferation of ARID1A-mutated cancer cells in vitro and in vivo, respectively, but not in the wild type cells. The gene discussed is ARID1A; the disease is cancer.